Meanwhile, breast cancer patients carrying the CYP1A2 rs2470890 TT genotype had a poorer OS compared to those with the CC genotype (HR = 3.410, 95% CI 1.535–7.575, P = 0.003, Table 3). This evidence concerns the gene CYP1A2 and breast carcinoma.